Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management
Rectal CancerCAPECITABINE (ORAL)FLUOROURACILLEUCOVORINOXALIPLATINTotal mesorectal excisionChemoradiation therapyTotal neoadjuvant therapy13-213Rectal NeoplasmsCapecitabineOxaliplatin (OXAL)5-Fluorouracil (5-FU)Capecitabine (Xeloda®)intensity modulated radiotherapy (IMRT)Quality of Life QuestionnairesDRE-EndoscopyINCTCNCT
Lead Scientist at UCSF
- Madhulika Varma
Dr. Madhulika Varma, Chief of Colorectal Surgery, specializes in the surgical treatment of diseases of the colon, rectum, and anus. Her areas of expertise include colon and rectal cancer, inflammatory bowel diseases such as ulcerative colitis, Crohn’s disease, and pelvic floor disorders.